Managed Care Pharmacy Encounters Paid to Meadowbrook Pharmacy
Learn how the AI-generated research projects were createdOverall Conclusion
Meadowbrook Pharmacy filled and dispensed prescriptions for Texas Medicaid and CHIP members; however, Meadowbrook did not consistently comply with certain requirements for dispensing refills, accurately submitting claims, providing instructions for use, and maintaining supporting documentation. As a result, Meadowbrook was overpaid and should repay $958.08 to the state of Texas.
Source Document
Audit Scope
October 1, 2019, through August 31, 2022
Key Findings Summary
One claim for an unauthorized refill, resulting in an overpayment totaling $552.74.
Four claims with unauthorized medication substitutions, resulting in an overpayment totaling $6.52.
One claim missing confirmation of medication delivery, resulting in an overpayment of $323.69.
View the Findings tab to see all 6 findings
AI-Assisted
AI Scope Summary
This audit's objective was to determine whether Meadowbrook properly dispensed prescriptions for Texas Medicaid and CHIP members enrolled with Cook Children’s Health Plan and Wellpoint and whether Meadowbrook complied with contractual, state, and federal requirements. The scope covered October 1, 2019, through August 31, 2022, and concluded with an overpayment of $958.08 to the state. The findings highlight inconsistent dispensing, submission, labeling, and documentation practices, guiding future audits on dispensing accuracy, claims validation, and documentation retention.
AI-Generated Insight
The Meadowbrook audit identifies control gaps in dispensing accuracy, documentation, and data submission, resulting in an overpayment of $958.08. Strengthening verification, labeling, and documentation processes can improve compliance for Texas Medicaid managed care pharmacies.
Audit Objectives
Determine whether Meadowbrook properly dispensed prescriptions associated with selected encounters for Texas Medicaid and CHIP members enrolled with Cook Children’s Health Plan and Wellpoint.
Determine whether Meadowbrook complied with applicable contractual, state, and federal requirements.
Audit Findings (6)
One claim for an unauthorized refill, resulting in an overpayment totaling $552.74.
Four claims with unauthorized medication substitutions, resulting in an overpayment totaling $6.52.
One claim missing confirmation of medication delivery, resulting in an overpayment of $323.69.
Two claims with an inaccurate days’ supply to circumvent MCO limits, resulting in overpayments totaling $75.13.
One claim with a dispensing label containing incomplete instructions for use.
Six claims for compounded medications without documentation of the methodology, equipment, or container used.
Recommendations (4)
Improve dispensing processes to fill prescriptions as authorized by the prescriber and document medication delivery.
Update prescription verification process to verify the accuracy of information entered in the pharmacy system and submitted as claims.
Update claims submission process to validate the days’ supply before submitting each claim.
Implement a process to print dispensing labels with complete instructions for use.